Literature DB >> 15682361

Tc-99m sestamibi infarct size as a surrogate endpoint.

Raymond J Gibbons, Todd D Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15682361     DOI： 10.1016/j.nuclcard.2004.10.002

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  38 in total

Review 1.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

Authors:  R J Gibbons; T D Miller; T F Christian
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

3.  Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).

Authors:  David E Kandzari; Alan Chu; Bruce R Brodie; Thomas A Stuckey; James B Hermiller; George W Vetrovec; Karen L Hannan; Mitchell W Krucoff; Robert H Christenson; Raymond J Gibbons; Kristina N Sigmon; Jyostna Garg; Victor Hasselblad; Kenneth Collins; Robert A Harrington; Peter B Berger; Nicholas A Chronos; Judith S Hochman; Robert M Califf
Journal:  Am J Cardiol       Date:  2004-03-01       Impact factor: 2.778

4.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

5.  In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi).

Authors:  M K O'Connor; T Hammell; R J Gibbons
Journal:  Eur J Nucl Med       Date:  1990

6.  Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.

Authors:  J H O'Keefe; C L Grines; M A DeWood; G L Schaer; K Browne; R D Magorien; J M Kalbfleisch; W O Fletcher; T M Bateman; R J Gibbons
Journal:  Am J Cardiol       Date:  1996-10-01       Impact factor: 2.778

7.  Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area.

Authors:  M Galli; C Marcassa; R Bolli; P Giannuzzi; P L Temporelli; A Imparato; P L Silva Orrego; R Giubbini; A Giordano; L Tavazzi
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

8.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

9.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

10.  Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

Authors:  L K Newby; W R Rutsch; R M Califf; M L Simoons; P E Aylward; P W Armstrong; L H Woodlief; K L Lee; E J Topol; F Van de Werf
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094
View more
  3 in total

Review 1.  SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability.

Authors:  George A Beller; Ruth C Heede
Journal:  J Cardiovasc Transl Res       Date:  2011-07-06       Impact factor: 4.132

2.  Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction.

Authors:  Valentina Berti; Roberto Sciagrà; Wanda Acampa; Francesca Ricci; Giampaolo Cerisano; Rosj Gallicchio; Carlo Vigorito; Alberto Pupi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

3.  Prognostic value of myocardial perfusion-gated SPECT in patients with ischemic cardiomyopathy.

Authors:  Jaume Candell-Riera; Guillermo Romero-Farina; Santiago Aguadé-Bruix; Joan Castell-Conesa; Gustavo de León; David García-Dorado
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.